Brentuximab vedotin in patients at increased risk of Hodgkin lymphoma progression post autologous stem cell transplant: Evaluation of healthcare resource utilization in the AETHERA trial Meeting Abstract


Authors: Bonthapally, V.; Ma, E.; Viviani, S.; Radford, J.; Brice, P.; von Tresckow, B.; Thomas, E.; Teasell, J.; Gnanasakthy, A.; Odom, D.; Zhu, Y.; Lee, S. Y.; Carlson, P.; Huebner, D.; Sweetenham, J.; Moskowitz, C.; Walewski, J.
Abstract Title: Brentuximab vedotin in patients at increased risk of Hodgkin lymphoma progression post autologous stem cell transplant: Evaluation of healthcare resource utilization in the AETHERA trial
Meeting Title: 20th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2015 Jun 11-14
Meeting Location: Vienna, Austria
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-06-01
Start Page: 579
End Page: 580
Language: English
ACCESSION: WOS:000361204903431
PROVIDER: wos
PMCID: PMC4480587
Notes: Meeting Abstract: E1448 -- Source: Wos
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz